MYC and Burkitt lymphoma: Colomo et al. [24] investigated BL as well, but also cases of DLBCL with MYC and BCL2/6 translocations to see whether they could prescreen cases with immunohistochemistry to avoid mutation testing in many DLBCL cases without MYC translocation.